0001437749-23-002358.txt : 20230202
0001437749-23-002358.hdr.sgml : 20230202
20230202154058
ACCESSION NUMBER: 0001437749-23-002358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230131
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Elizabeth A.
CENTRAL INDEX KEY: 0001764157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 23580629
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-01-31
0001668243
UroGen Pharma Ltd.
URGN
0001764157
Barrett Elizabeth A.
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Executive Officer
Ordinary Shares
2023-01-31
4
M
0
5000
A
313358
D
Ordinary Shares
2023-01-31
4
M
0
13333
A
326691
D
Restricted Stock Units
2023-01-31
4
M
0
5000
0
D
Ordinary Shares
5000
0
D
Restricted Stock Units
2023-01-31
4
M
0
13333
0
D
Ordinary Shares
13333
13334
D
Restricted Stock Units
2023-01-31
4
A
0
75000
0
A
Ordinary Shares
75000
75000
D
Employee Stock Option (right to buy)
10.39
2023-01-31
4
A
0
125000
0
A
2033-01-31
Ordinary Shares
125000
125000
D
Performance Stock Units
2023-01-31
4
A
0
100000
0
A
Ordinary Shares
100000
100000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021.
The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026.
Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Issuer.
All shares underlying the performance stock units will vest upon achievement of a corporate milestone event.
The performance stock units were approved by the Board of Directors of the Issuer on January 31, 2023. If the performance stock units are not ratified by the Issuer's shareholders at the Issuer's 2023 annual general meeting, the performance stock units will terminate.
/s/ Jason D. Smith, Attorney-in-Fact
2023-02-02